Comparisons between SARS-CoV-2 specific IgG and IgA antibody levels in participants with and without symptoms of chemosensory dysfunction at the same time point or during the first infection showed no significant difference (Figure A3A for IgG and A3B for IgA). This evidence concerns the gene CD79A and infection.